U.S. FDA approves Gileads $94,500 hepatitis C drug - TopicsExpress



          

U.S. FDA approves Gileads $94,500 hepatitis C drug (Reuters) – U.S. regulators on Friday approved a new hepatitis C pill from Gilead Sciences Inc, which said it will charge $94,500 for an improved 12-week course of treatment to rid patients of the liver-destroying viral infection. The daily pill, to be sold under the brand name... anactivelife/wordpress/2014/10/u-s-fda-approves-gileads-94500-hepatitis-c-drug/
Posted on: Fri, 10 Oct 2014 20:45:44 +0000

Recently Viewed Topics




© 2015